4.0927

0.61% -0.0027

Intensity Therapeutics Inc (INTS)

Überblick Nachrichten Preisverlauf Financials Warum fällt INTS? Forum Prognose

Schlusskurs vom Vortag:

$4.09

Offen:

$4.12

24-Stunden-Volumen:

1,667

Relative Volume:

0.04

Marktkapitalisierung:

$13.33M

Einnahmen:

Nettoeinkommen (Verlust:

$-10.69M

KGV:

-0.5779

EPS:

-7.0818

Netto-Cashflow:

$-9.07M

1W Leistung:

+1.63%

1M Leistung:

-2.28%

6M Leistung:

-47.68%

1J Leistung:

-42.58%

1-Tages-Spanne:

$3.99

$4.12

1-Wochen-Bereich:

$3.99

$4.13

52-Wochen-Spanne:

$3.51

$43.50

Intensity Therapeutics Inc Stock (INTS) Company Profile

Firmenname

Intensity Therapeutics Inc

Sektor

Healthcare (1087)

Branche

Biotechnology (606)

Telefon

203-221-7381

Adresse

1 ENTERPRISE DRIVE, SUITE 430, SHELTON

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

INTS's Discussions on Twitter

Compare INTS vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INTS Intensity Therapeutics Inc	4.0814	13.35M	0	-10.69M	-9.07M	-7.0818
VRTX Vertex Pharmaceuticals Inc	522.64	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	804.34	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,002.89	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.62	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.08	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten

Sep 08, 2026

Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire

Sep 08, 2026

Sep 06, 2026

Why Did INTS Stock Plummet 25% Today? - Stocktwits

Sep 06, 2026

Sep 02, 2026

All You Need to Know About Actuate Therapeutics, Inc. (ACTU) Rating Upgrade to Buy - Yahoo Finance

Sep 02, 2026

Aug 26, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm

Aug 26, 2026

Aug 24, 2026

Intensity (INTS) Quarterly Scorecard: EPS Comes in Above Forecast in the Latest Reading; Shares Close 0.41% Lower at the CloseForward EPS Estimate - vinanet.vn

Aug 24, 2026

Aug 23, 2026

Intensity (INTS) Snapshot: Moves 0.41% Down to $4.86; Immediate View: the Current Price Sits Inside the Supplied Technical Range on the DayLate Stage Breakouts - vinanet.vn

Aug 23, 2026

Intensity (INTS) Quarterly Results: Profit Per Share Clears Its Benchmark; Closing Reaction: Shares Move 0.41% LowerDividend Increase Stocks - vinanet.vn

Aug 23, 2026

Aug 19, 2026

Intensity (INTS) Results Review: EPS Comes in Above Forecast in the Current Update - vinanet.vn

Aug 19, 2026

H.C. Wainwright Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Maintains Target Price $7 - Moomoo

Aug 19, 2026

H.C. Wainwright reiterates Buy on Intensity Therapeutics stock By Investing.com - Investing.com Canada

Aug 19, 2026

H.C. Wainwright reiterates Buy on Intensity Therapeutics stock - Investing.com

Aug 19, 2026

Analysts Offer Insights on Healthcare Companies: Quoin Pharmaceuticals (QNRX) and Pliant Therapeutics (PLRX) - The Globe and Mail

Aug 19, 2026

Aug 18, 2026

INTS Stock Price, Quote & Chart - ChartMill

Aug 18, 2026

INTENSITY THERAPEUTICS, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $7 FROM $5 - Bitget

Aug 18, 2026

INTS Maintained by HC Wainwright & Co. -- Price Target Raised to $7.00 - GuruFocus

Aug 18, 2026

H.C. Wainwright Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Cuts Target Price to $7 - Moomoo

Aug 18, 2026

Aug 16, 2026

Intensity Therapeutics (INTS) Dips 1% to $3.96, Trading Range Holds with Support at $3.76Zero Lag EMA - vinanet.vn

Aug 16, 2026

Aug 12, 2026

Earnings call transcript: Intensity Therapeutics misses Q2 2026 EPS as shares slip premarket - Investing.com UK

Aug 12, 2026

Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript - aol.com

Aug 12, 2026

Aug 11, 2026

Intensity Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 11, 2026

A. G. P. Maintains Intensity Therapeutics(INTS.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

Aug 11, 2026

Intensity Therapeutics Warns of Substantial Doubt - Minichart

Aug 11, 2026

Intensity Therapeutics Q2 Results: EPS loss narrows 67% YoY - scanx.trade

Aug 11, 2026

INTS: Q2 2026 saw higher R&D spend, resumed trial enrollment, and strong early TNBC efficacy data - TradingView

Aug 11, 2026

Transcript : Intensity Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com

Aug 11, 2026

Form 8K Intensity Therapeutics Inc For: 11 August By Investing.com - Investing.com Australia

Aug 11, 2026

INTS: Net loss rose 19% to $3M as clinical trials resumed, with $9.5M cash and $30M more needed for completion - TradingView

Aug 11, 2026

Intensity Therapeutics (INTS) Advances Clinical Trials Amidst Ch - GuruFocus

Aug 11, 2026

Intensity Therapeutics Reports $3.0 Million Q2 Net Loss - Quiver Quantitative

Aug 11, 2026

Intensity Therapeutics reports Q2 2026 net loss of $3.0M, cash $9.5M; resumes select trial enrollment - TradingView

Aug 11, 2026

Intensity Therapeutics Q2 net loss widens as R&D costs rise - TradingView

Aug 11, 2026

INTS: Resumed clinical trial enrollment and raised capital, with improved early TNBC study results - TradingView

Aug 11, 2026

BRIEF-Intensity Therapeutics Q2 Operating Income USD -3.084 Million - TradingView

Aug 11, 2026

Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - PR Newswire

Aug 11, 2026

INTENSITY THERAPEUTICS, INC. Q2 2026: Net income $(3.0M), EPS $(1.11) — 10-Q Summary - TradingView

Aug 11, 2026

Intensity Therapeutics (INTS) Holds Steady Near $4.28 as Biotech Stock Consolidates Within RangeComposite Profile - vinanet.vn

Aug 11, 2026

Aug 10, 2026

INTS Q2'26 Earnings: EPS estimate is (0.87) USD - TradingView

Aug 10, 2026

Aug 09, 2026

BRIEF-Intensity Therapeutics Q1 Operating Income USD -2.526 Million - TradingView

Aug 09, 2026

Aug 07, 2026

Intensity Therapeutics (INTS.US) will release its earnings report on August 11. - Moomoo

Aug 07, 2026